214 related articles for article (PubMed ID: 35193647)
21. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
22. Positive feedback loop of YB-1 interacting with Smad2 promotes liver fibrosis.
Xiong P; Zhang J; Xu D; Zhu J; Li W; Liu J; Liu F
Biochem Biophys Res Commun; 2017 Mar; 484(4):753-761. PubMed ID: 28153731
[TBL] [Abstract][Full Text] [Related]
23. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
[TBL] [Abstract][Full Text] [Related]
24. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
Sengupta S; Jana S; Bhattacharyya A
Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
[TBL] [Abstract][Full Text] [Related]
25. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
[TBL] [Abstract][Full Text] [Related]
26. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism.
Mirzoeva S; Franzen CA; Pelling JC
Mol Carcinog; 2014 Aug; 53(8):598-609. PubMed ID: 23359392
[TBL] [Abstract][Full Text] [Related]
27. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
28. Recombinant TSG-6 protein inhibits the growth of capsule fibroblasts in frozen shoulder via suppressing the TGF-β/Smad2 signal pathway.
Liu Z; Pei Y; Zeng H; Yang Y; Que M; Xiao Y; Wang J; Weng X
J Orthop Surg Res; 2021 Sep; 16(1):564. PubMed ID: 34526039
[TBL] [Abstract][Full Text] [Related]
29. TSC1 activates TGF-β-Smad2/3 signaling in growth arrest and epithelial-to-mesenchymal transition.
Thien A; Prentzell MT; Holzwarth B; Kläsener K; Kuper I; Boehlke C; Sonntag AG; Ruf S; Maerz L; Nitschke R; Grellscheid SN; Reth M; Walz G; Baumeister R; Neumann-Haefelin E; Thedieck K
Dev Cell; 2015 Mar; 32(5):617-30. PubMed ID: 25727005
[TBL] [Abstract][Full Text] [Related]
30. TGF-β/Smad2/3 signaling directly regulates several miRNAs in mouse ES cells and early embryos.
Redshaw N; Camps C; Sharma V; Motallebipour M; Guzman-Ayala M; Oikonomopoulos S; Thymiakou E; Ragoussis J; Episkopou V
PLoS One; 2013; 8(1):e55186. PubMed ID: 23390484
[TBL] [Abstract][Full Text] [Related]
31. Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer.
Zhang B; Ye H; Ren X; Zheng S; Zhou Q; Chen C; Lin Q; Li G; Wei L; Fu Z; Zhang Y; Hu C; Li Z; Chen R
Cancer Lett; 2019 Sep; 459():204-215. PubMed ID: 31199988
[TBL] [Abstract][Full Text] [Related]
32. A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.
Rojas A; Zhang P; Wang Y; Foo WC; Muñoz NM; Xiao L; Wang J; Gores GJ; Hung MC; Blechacz B
Neoplasia; 2016 Jun; 18(6):371-86. PubMed ID: 27292026
[TBL] [Abstract][Full Text] [Related]
33. Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer.
Lee JE; Lee P; Yoon YC; Han BS; Ko S; Park MS; Lee YJ; Kim SE; Cho YJ; Lim JH; Ryu JK; Shim S; Kim DK; Jung KH; Hong SS
Biomed Pharmacother; 2023 Jun; 162():114716. PubMed ID: 37086509
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating the TGF/β-Smad2/3 signaling pathway.
Zhao T; Sun R; Ma X; Wei L; Hou Y; Song K; Jiang J
Acta Biochim Biophys Sin (Shanghai); 2022 Jun; 54(7):904-916. PubMed ID: 35880567
[TBL] [Abstract][Full Text] [Related]
35. MT1-MMP cooperates with Kras(G12D) to promote pancreatic fibrosis through increased TGF-β signaling.
Krantz SB; Shields MA; Dangi-Garimella S; Cheon EC; Barron MR; Hwang RF; Rao MS; Grippo PJ; Bentrem DJ; Munshi HG
Mol Cancer Res; 2011 Oct; 9(10):1294-304. PubMed ID: 21856775
[TBL] [Abstract][Full Text] [Related]
36. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
Ijichi H; Chytil A; Gorska AE; Aakre ME; Fujitani Y; Fujitani S; Wright CV; Moses HL
Genes Dev; 2006 Nov; 20(22):3147-60. PubMed ID: 17114585
[TBL] [Abstract][Full Text] [Related]
37. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Smad2 and colocalization with TGF-beta1 in human pancreatic cancer.
Kleeff J; Friess H; Simon P; Susmallian S; Büchler P; Zimmermann A; Büchler MW; Korc M
Dig Dis Sci; 1999 Sep; 44(9):1793-802. PubMed ID: 10505717
[TBL] [Abstract][Full Text] [Related]
39. Collagen Type VI Alpha 3 Chain Promotes Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Transforming Growth Factor β (TGF-β)/Smad Pathway.
Huang Y; Li G; Wang K; Mu Z; Xie Q; Qu H; Lv H; Hu B
Med Sci Monit; 2018 Aug; 24():5346-5354. PubMed ID: 30066698
[TBL] [Abstract][Full Text] [Related]
40. Direct inhibition of the transforming growth factor-β pathway by protein-bound polysaccharide through inactivation of Smad2 signaling.
Ono Y; Hayashida T; Konagai A; Okazaki H; Miyao K; Kawachi S; Tanabe M; Shinoda M; Jinno H; Hasegawa H; Kitajima M; Kitagawa Y
Cancer Sci; 2012 Feb; 103(2):317-24. PubMed ID: 22034928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
